Random Biopsy Improves Dysplasia Detection In Patients With IBD, Research Suggests

GI & Hepatology News (1/31, Pass) reported, “Random biopsy during colonoscopy improves dysplasia detection among patients with inflammatory bowel disease (IBD), but level of benefit depends on equipment and disease characteristics, according to a recent review and meta-analysis.” Researchers found that “random biopsies collected in studies after 2011 provided limited additional yield, suggesting that high-definition equipment alone may be sufficient to achieve a high detection rate.” Meanwhile, “patients with primary sclerosing cholangitis consistently benefited from random biopsy, offering clearer support for use in this subgroup.” The findings were published in Clinical Gastroenterology and Hepatology.